| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 18.70 | 0.00 (0.00%) | 15.39 - 25.79 | 0.0 |
Market data as of 12:00AM 05/20/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 18.70 |
| Day's Range | -- - -- |
| Market Cap | 777.7M |
| Avg Volume (10 Day) | 303.4K |
| Price/Earnings (Trailing 12 Mo.) | 116.9x |
| Earnings Per Share (Trailing 12 Mo.) | 0.16 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Luminex Corporation To Present At Upcoming Investment Conferences
PR Newswire - Tuesday 05/07/2013 4:05 PM ET
Luminex Corporation Reports First Quarter 2013 Results
PR Newswire - Monday 04/29/2013 4:05 PM ET
| LMNX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 9.10% | |
| Net Income Growth (1yr) | -52.96% | |
| Total Debt/Equity | 0.01 | |
| LT Debt/Equity | 0.01 | |
| Earnings Yield | 0.86% | |
| Price/Sales | 3.76 |
| Company | Last | Change |
|---|---|---|
| Tornier NV | 16.95 | 0.00% |
| Endologix Inc | 14.10 | 0.00% |
| Cantel Medical Corp | 34.44 | 0.00% |
| ICU Medical Inc | 68.62 | 0.00% |
| Conceptus Inc | 30.92 | 0.00% |
Data is delayed by at least 15 min.